Management of patients with arterial hypertension and heart rate over 80 bpm: resolution of the expert council; Ведение пациентов с артериальной гипертензией и частотой сердечных сокращений более 80 уд/мин: резолюция совета экспертов

Сlinical and population studies have shown that elevated heart rate (HR) in patients with arterial hypertension significantly increases the risk of organ damage, development of cardiovascular events and overall mortality. Therefore, measurement of resting HR should be a component of standard hypertensive patients examination. This simple parameter was shown to reliably reflect sympathetic nervous system activity. A cutoff point for resting HR over 80 beats per minute (bpm) has been proposed to be a marker of sympathetic overdrive and an independent cardiovascular risk factor. However, the rationale and target for HR reduction in hypertension without cardiovascular diseases are still controversial. It is necessary to take into account the tolerance of tachycardia, blood pressure level, the HR level and comorbidity before starting HR reduction therapy. Increased resting HR may be a clinical sign of sympathetic overdrive, but also a symptom of anemia, thyrotoxicosis, hypovolemia, chronic heart failure, and other conditions. It is also necessary to consider patient's metabolic status and lifestyle. Thе review summarizes expert council opinion on the management of patients with hypertension and HR over 80 bpm, including the issue of beta-blocker indications. © 2025 Elsevier B.V., All rights reserved.

Авторы
Alexandra О. (Konradi) 1 , Karpov Yu Aleksandrovich 2 , Shalnova Svetlana A. 3 , Koziolova N.A. 4 , Matskeplishvili Simon T. 5 , Nedogoda S.V. 6 , Gilyarevskiy Sergey R. 7 , Kashtalap Vasily V. 8, 9 , Kisliak Oksana A. 10 , Zyryanov S.K. 11, 12 , Zhirov Igor V. 7, 13
Издательство
Национальный медицинский исследовательский центр им. В.А. Алмазова
Номер выпуска
2
Язык
Russian
Страницы
82-97
Статус
Published
Том
31
Год
2025
Организации
  • 1 Research Department for Hypertension, Almazov National Medical Research Centre, Saint Petersburg, Russian Federation
  • 2 Department of Angiology, National medical research center of cardiology of the Ministry of healthcare of the Russian Federation, Moscow, Russian Federation
  • 3 Department of Epidemiology of Chronic Non-Communicable Diseases, National Medical Research Center for Therapy and Preventive Medicine, Moscow, Russian Federation
  • 4 E.A.Vagner Perm State Medical University, Perm, Russian Federation
  • 5 Medical Scientific and Educational Institute, Lomonosov Moscow State University, Moscow, Russian Federation
  • 6 Institute of Continuing Medical and Pharmaceutical Education, Volgogradskij Gosudarstvennyj Medicinskij Universitet, Volgograd, Russian Federation
  • 7 Russian Medical Academy of Continuous Professional Education, Moscow, Russian Federation
  • 8 Department of Clinical Cardiology, Kuzbass Cardiology Center SB RAS, Kemerovo, Russian Federation
  • 9 Kemerovo State Medical Academy, Kemerovo, Russian Federation
  • 10 Pirogov Russian National Research Medical University (RNRMU), Moscow, Russian Federation
  • 11 RUDN University, Moscow, Russian Federation
  • 12 City Clinical Hospital No. 24, Moscow, Russian Federation
  • 13 Department for the Diseases of Myocardium and Heart Failure, National medical research center of cardiology of the Ministry of healthcare of the Russian Federation, Moscow, Russian Federation
Ключевые слова
antihypertensive agents; beta-blockers; cardiovascular diseases; cardiovascular risk factors; heart rate; hypertension
Цитировать
Поделиться

Другие записи

Avatkov V.A., Apanovich M.Yu., Borzova A.Yu., Bordachev T.V., Vinokurov V.I., Volokhov V.I., Vorobev S.V., Gumensky A.V., Иванченко В.С., Kashirina T.V., Матвеев О.В., Okunev I.Yu., Popleteeva G.A., Sapronova M.A., Свешникова Ю.В., Fenenko A.V., Feofanov K.A., Tsvetov P.Yu., Shkolyarskaya T.I., Shtol V.V. ...
Общество с ограниченной ответственностью Издательско-торговая корпорация "Дашков и К". 2018. 411 с.